Wellgistics Health, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

24 Apr 2026

WGRX

10-K/A: Wellgistics Health 10-K/A: Governance & Disclosure Update

Wellgistics Health, Inc. filed an amendment to its 2025 Annual Report to restate governance disclosures and include a formal clawback policy.

NASDAQ

20 Mar 2026

WGRX

Wellgistics Health, INC

10-K: Wellgistics Health Reports $101M Loss, Nasdaq Delisting Risk

Wellgistics Health reported a significant net loss of $101.3 million for 2025, facing Nasdaq delisting concerns and substantial debt obligations.

NASDAQ

25 Mar 2025

WGRX

Wellgistics Health, INC

10-K: Wellgistics Health Releases Code of Ethics and Annual Report, Outlines Growth Strategy

Wellgistics Health, a holding company focused on pharmaceuticals and healthcare services, releases its Code of Business Conduct and Ethics and its annual report, detailing its business strategy and financial performance for the year ended December 31, 2024.